Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Transcutaneous Vagus Nerve Stimulation in Neuroprotection and the Reduction of the Systemic Inflammatory Response in Acute Brain Injury

NCT07384845 is registered in ClinicalTrials.gov with Clinical Hospital Centre Zagreb as lead sponsor.

NCT NCT07384845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07384845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Transcutaneous Vagus Nerve Stimulation in Neuroprotection and the Reduction of the Systemic Inflammatory Response in Acute Brain Injury
Lead sponsor
Clinical Hospital Centre Zagreb
Phase
Not applicable
Overall status
Not yet recruiting
Start date
February 28, 2026
Completion date
February 29, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute brain injury, immunomodulation, neuromodulation, transcutaneous vagus nerve stimulation